Texel Patents – Insights & Stats (Updated 2024)

Texel has a total of 14 patents globally, out of which 7 have been granted. Of these 14 patents, none patents are active. The United States is where Texel has filed the maximum number of patents, followed by Canada. Parallelly, France seems to be the main focused R&D center of Texel and UAE is the origin country of the firm.

Texel was founded in the year 2014 by Andrey Poskonin, Maxim Fedyukov and Sergey Klimentyev. The company is a developer of software solutions for size recommendation & virtual try-on and manufacturer of full-body 3D scanners.

Do read about some of the most popular patents of Texel which have been covered by us in this article and also you can find Texel patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Texel patent portfolio.

How many patents does Texel have?

Texel has a total of 14 patents globally. These patents belong to 14 unique patent families. Out of 14 patents, none patents are active.

How Many Patents did Texel File Every Year?

Texel Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

How many Texel patents are Alive/Dead?

Worldwide Patents

Of the 14 patents filed by Texel, none of them are active.

How Many Patents did Texel File in Different Countries?

Texel  Worldwide Patent Filing

Countries in which Texel Filed Patents

CountryPatents
United States Of America3
Canada2
Australia1
Poland1
Japan1
New Zealand1
Denmark1
Austria1
Spain1
Europe1
France1

Where are Research Centres of Texel Patents Located?

R&D Centres of Texel

Most Cited Texel Patent

US6528285B1 is the most popular patent in the Texel portfolio. It has received 11 citations so far from companies like Syngulon.

List of Texel Patents

Publication NumberTitle
US6528285B1Non Rcr Leuconostoc Plasmid Capable Of Being Transferred Into Lactic Acid Bacteria, Use As Cloning And Expressing Tool
US20060154032A1Washcloth With Water Reactive Motifs
US20030126792A1Mechanical Barrier To Block The Growth Of Plant And Tree Roots
EP1056350B1Cheese Flavouring Composition
CA2581536A1Capillary Carpet Irrigation Device
CA2393091A1Mechanical Barrier Against Roots
JP2004530862AMicroplate Cover Assembly
AT230934TZusammenzetzung Zur Aromatisierung Von Käse
FR2798669B1Strain Of Lactobacillus Delbrueckii And Its Use For Plasmid Screening
NZ504222BNon-Rcr Leuconostoc Plasmid Capable Of Being Transferred Into Lactic Acid Bacteria; Use As Cloning And Expressing Tool
ES2191416T3Cheese Flavouring Composition
DK1056350T3Composition For Flavoring Cheese
AU757723B2Non Rcr Leuconostoc Plasmid Capable Of Being Transferred Into Lactic Acid Bacteria; Use As Cloning And Expressing Tool
PL354101A1Use Of Strains Of Streptococcus Thermophilus Which Are Incapable Of Hydrolyzing Urea In Dairy Products

What are Texel key innovation segments?

What Technologies are Covered by Texel?

The chart below distributes patents filed by Texel in different countries on the basis of the technology protected in patents. It also represents the markets where Texel thinks it’s important to protect particular technology inventions.

R&D Focus: How has Texel search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Texel?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.